OBJECTIVETo compare the risks of severe hypoglycemia and mortality between patients with type 2 diabetes (T2D) and...
Auteur - American Diabetes Association - Care
Patient-Reported Outcomes of COVID-19 Vaccine Breakthrough...
Despite the effectiveness of mRNA vaccines in preventing severe coronavirus disease 2019 (COVID-19) (1), infections...
Erratum. Targeting Technology in Underserved Adults With Type 1...
In the article cited above, funding information was inadvertently omitted for author Priyanka Mathias. Financial support for...
Sustained Low Income, Income Changes, and Risk of All-Cause Mortality...
OBJECTIVEThere is limited evidence on the association of sustained low-income status, income changes, and all-cause...
Low-Dose Empagliflozin as Adjunct to Hybrid Closed-Loop Insulin...
OBJECTIVETo assess whether low doses of empagliflozin as adjunct to hybrid closed-loop therapy improve glycemia compared...
GlyCulator 3.0: A Fast, Easy-to-Use Analytical Tool for CGM Data...
Continuous glucose monitoring (CGM) has become the target standard of care for people with diabetes and an abundant source...
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
OBJECTIVETo determine whether use of glucagon-like peptide 1 (GLP-1) receptor agonists (RA) is associated with increased...
Trends in Metformin Use Among Patients With Prediabetes: 2008–2020
Since 2008, the American Diabetes Association has recommended metformin as an adjunct to intensive lifestyle intervention...
Association Between Glycemic Status and the Risk of Kidney Cancer in...
OBJECTIVEKidney cancer predominantly affects men, suggesting a biological protection against kidney cancer in women. We...
Phenotype and Lifestyle Intervention: Potential for Predicting and...
National Institute of Diabetes and Digestive and Kidney Diseases10.13039/100000062P30-DK111022